Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Tenax Therapeutics (TENX) Return on Equity (2016 - 2026)

Tenax Therapeutics' Return on Equity history spans 5 years, with the latest figure at 0.01% for Q4 2017.

  • On a quarterly basis, Return on Equity rose 1.0% to 0.01% in Q4 2017 year-over-year; TTM through Dec 2017 was 0.01%, a 1.0% increase, with the full-year FY2017 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2017 for Tenax Therapeutics, up from 0.06% in the prior quarter.
  • Over the last five years, Return on Equity for TENX hit a ceiling of 0.12% in Q1 2013 and a floor of 0.06% in Q3 2017.
  • Historically, Return on Equity has averaged 0.0% across 3 years, with a median of 0.01% in 2017.
  • The widest YoY moves for Return on Equity: up 8bps in 2013, down -20bps in 2013.
  • Tracing TENX's Return on Equity over 3 years: stood at 0.06% in 2013, then plummeted by -136bps to 0.02% in 2016, then soared by 52bps to 0.01% in 2017.
  • Business Quant data shows Return on Equity for TENX at 0.01% in Q4 2017, 0.06% in Q3 2017, and 0.04% in Q2 2017.